Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
The MIT-sponsored competition encourages community approaches to developing new solutions for analyzing graphs and sparse data; PNNL has placed a winner in each year.
An award-winning ion separation technology developed at PNNL has been licensed for biomedical applications. Continued research aims to make the devices suitable for molecular analysis in the field.
Soil microbial communities produced more water retaining molecules when enriched with insoluble organic carbon, chitin, compared to a soluble carbon source, N-acetylglucosamine.
Using a large repository of blood samples from military personnel, PNNL and Uniformed Services University scientists have discovered a group of 13 proteins that could provide early detection of head and neck cancers.
The American Society for Quality (ASQ) has recognized Laboratory Fellow and Pacific Northwest National Laboratory (PNNL) Statistician Greg Piepel with the William G. Hunter Award.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.